Published in J Neurol on March 13, 2009
Effects of Chocolate on Motor Symptoms of Parkinson's Disease (ChocoPD) | NCT00906763
Mechanisms of body weight fluctuations in Parkinson's disease. Front Neurol (2014) 0.82
Parkinson's disease and 2009: recent advances. J Neurol (2010) 0.76
Comparison of chocolate to cacao-free white chocolate in Parkinson's disease: a single-dose, investigator-blinded, placebo-controlled, crossover trial. J Neurol (2012) 0.75
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
Body weight in patients with Parkinson's disease. Mov Disord (2006) 1.89
Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol (2005) 1.88
Brain cannabinoids in chocolate. Nature (1996) 1.78
Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci (2005) 1.60
Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering. Phytochemistry (2007) 1.34
Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm (Vienna) (2002) 1.21
Mood state effects of chocolate. J Affect Disord (2006) 0.97
Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology (1995) 0.94
Taste responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2005) 0.93
Chocolate craving when depressed: a personality marker. Br J Psychiatry (2007) 0.92
Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease? Ann Neurol (2008) 0.84
Determination of biogenic amines in chocolate by ion chromatographic separation and pulsed integrated amperometric detection with implemented wave-form at Au disposable electrode. J Chromatogr A (2005) 0.80
Depression and self-reported depressive symptoms in multiple system atrophy compared to Parkinson's disease. Mov Disord (2006) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell (2012) 4.28
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology (2013) 2.99
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One (2008) 2.46
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int (2010) 2.27
Primary closure techniques in chronic pilonidal sinus: a survey of the results of different surgical approaches. Dis Colon Rectum (2002) 2.17
Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One (2010) 2.15
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol (2012) 2.15
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol (2003) 2.14
Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol (2011) 2.12
CARD15 genotype and phenotype analysis in 55 pediatric patients with Crohn disease from Saxony, Germany. J Pediatr Gastroenterol Nutr (2003) 2.11
Second cancers as competing causes of death after radical prostatectomy. J Urol (2009) 2.02
Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes Care (2008) 2.00
Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci (2004) 1.79
Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res (2010) 1.76
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol (2008) 1.62
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest (2008) 1.60
Treadmill training for patients with Parkinson's disease. Cochrane Database Syst Rev (2010) 1.54
Reliability of brain CT evaluation by stroke neurologists in telemedicine. Neurology (2012) 1.54
Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity (2012) 1.50
Places of death from cancer in a rural location. Onkologie (2007) 1.47
Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med (2006) 1.46
Autonomic function and cerebral autoregulation in patients undergoing carotid endarterectomy. Circ J (2010) 1.45
Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clin Rehabil (2005) 1.44
Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord (2007) 1.41
Dynamic contour tonometry in comparison to intracameral IOP measurements. Invest Ophthalmol Vis Sci (2008) 1.41
Risk-adjusted intraventricular hemorrhage rates in very premature infants: towards quality assurance between neonatal units. Dtsch Arztebl Int (2012) 1.39
Massive axial herniation after posterior fossa infarction following vertebral artery dissection. Neurology (2009) 1.38
Quantitative multi-gene expression profiling of primary prostate cancer. Prostate (2006) 1.36
Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep (2012) 1.36
Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord (2007) 1.35
Adherence to antiparkinson medication in a multicenter European study. Mov Disord (2009) 1.34
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol (2007) 1.34
Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology (2003) 1.29
Mitochondrial cytopathies. J Neurol (2003) 1.28
Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol (2004) 1.28
A systematic review and meta-analysis of the effects of clinical pathways on length of stay, hospital costs and patient outcomes. BMC Health Serv Res (2008) 1.26
Failure of adaptive self-organized criticality during epileptic seizure attacks. PLoS Comput Biol (2012) 1.25
Is surgery for multiple lung metastases reasonable? A total of 328 consecutive patients with multiple-laser metastasectomies with a new 1318-nm Nd:YAG laser. J Thorac Cardiovasc Surg (2006) 1.25
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (2010) 1.24
EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease. Mov Disord (2014) 1.23
Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation (2010) 1.22
Genes associated with Parkinson syndrome. J Neurol (2008) 1.21
The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells (2007) 1.21
A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials (2009) 1.19
Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol (2005) 1.14
Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols. J Neurosci Res (2006) 1.14
Neuroectodermally converted human mesenchymal stromal cells provide cytoprotective effects on neural stem cells and inhibit their glial differentiation. Cytotherapy (2010) 1.10
[Acute psychiatric day hospital treatment: is the effectiveness of this treatment approach still questionable?]. Psychiatr Prax (2004) 1.10
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Mov Disord (2011) 1.10
Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord (2004) 1.09
Charlson score and competing mortality. Cancer (2014) 1.09
Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the Childhood Diabetes Registry of Saxony, Germany. Horm Res Paediatr (2010) 1.08
Transdermal rotigotine for the perioperative management of Parkinson's disease. J Neural Transm (Vienna) (2010) 1.08
[On the efficacy of acute psychiatric day-care treatment in a one-year-follow-up. A comparison to inpatient treatment within a randomised controlled trial]. Psychiatr Prax (2006) 1.08
Histopathological analysis of skeletal muscle in patients with Parkinson's disease and 'dropped head'/'bent spine' syndrome. Parkinsonism Relat Disord (2009) 1.08
Comorbidity and mortality after brachytherapy: in regard to Nanda et al. Int J Radiat Oncol Biol Phys (2013) 1.07
Isolation of neural crest derived chromaffin progenitors from adult adrenal medulla. Stem Cells (2009) 1.07
Effect of age, tumor risk, and comorbidity in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 1.06
Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation. J Neurochem (2006) 1.06
Different odor tests contribute differently to the evaluation of olfactory loss. Chem Senses (2007) 1.05
Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci (2007) 1.05
Laser resection technique and results of multiple lung metastasectomies using a new 1,318 nm Nd:YAG laser system. Lasers Surg Med (2006) 1.02
Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord (2009) 1.02
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. J Neurol Sci (2006) 1.02
Depression and Parkinson's disease. J Neurol (2004) 1.02
Primary skin fibroblasts as a model of Parkinson's disease. Mol Neurobiol (2012) 1.01
Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem (2006) 1.01
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's disease. Mov Disord (2010) 1.00
Formation of cellular projections in neural progenitor cells depends on SK3 channel activity. J Neurochem (2007) 1.00
Clinical neuroprotection in Parkinson's disease - still waiting for the breakthrough. J Neurol Sci (2009) 1.00
A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol (2008) 1.00
Physical exercise increases Notch activity, proliferation and cell cycle exit of type-3 progenitor cells in adult hippocampal neurogenesis. Eur J Neurosci (2010) 1.00
Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells (2005) 1.00
Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy? BJU Int (2011) 1.00
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol (2003) 0.99
Cardiovascular autonomic dysfunction in Parkinson's disease. J Neurol Sci (2009) 0.99
Biopsies of olfactory epithelium in patients with Parkinson's disease. Mov Disord (2009) 0.99
Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation. Mol Neurodegener (2009) 0.98
An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis. PLoS One (2011) 0.98
Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells (2007) 0.97
Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors. J Neurochem (2005) 0.97
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. J Neurooncol (2008) 0.97
Developmental changes in cerebral autoregulatory capacity in the fetal sheep parietal cortex. J Physiol (2002) 0.97
Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet (2013) 0.96
Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells (2012) 0.96
Rostro-caudal gradual loss of cellular diversity within the periventricular regions of the ventricular system. Stem Cells (2009) 0.95
Olfactory dysfunction as a diagnostic marker for Parkinson's disease. Expert Rev Neurother (2009) 0.95
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma. Neuro Oncol (2010) 0.95
The influence of contractures and variation in measurement stretching velocity on the reliability of the Modified Ashworth Scale in patients with severe brain injury. Clin Rehabil (2005) 0.94
Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis. FASEB J (2012) 0.93
Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin Lab (2003) 0.93